On the basis of intrinsic molecular characteristics, breast cancer is classified into at least four subtypes: the HER2-enriched, basal-like, luminal A, and luminal B (HER2-positive and -negative) subtypes.2 This classification is closely associated with various pathological features, response to therapeutics and prognosis. The gene discussed is ERBB2; the disease is breast carcinoma.